3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Cholangiocarcinoma
1
Interventions
Cyclophosphamide
6
pembrolizumab
5
fludarabine phosphate
5
Vinblastine
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
fludarabine
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
pegfilgrastim
3
Etoposide
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Azacitidine
2
treosulfan
1
tocilizumab
1
thymoglobulin
1
tafasitamab
1
selinexor
1
polatuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
dehydroftorafur
×
30 days
×
Clear all
No trials found.